Thalia Therapeutics

Default features description for sign up page.

Regulatory news

Home

Media

AIM Rule 26

Open Sans

THALIA THERAPEUTICS INVESTOR CENTRE

N4 Pharma is pleased to extend an invitation for you to join our Investor Hub — a platform designed to enhance communication, information sharing, and engagement with our valued investors and shareholders. We warmly encourage our stakeholders to trial Investor Hub and to provide feedback.

N4 Pharma PLC - N4 Pharma Launches New Interactive Investor Hub

Announcement summary